Trial intelligence / Profile preview

Mannitol Administration During Partial Nephrectomy for Renal Function Preservation

jRCT1071250065Recruiting

Start
Sep 2025
Modality
Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Countries
1
01

Overview

Randomised trial of Bronchitol in renal cell carcinoma (RCC) (2 arms). Primary endpoint: Postoperative renal function preservation rate on the resected side. Started Sep 2025; status: recruiting.

02

Drugs

Bronchitol
03

Conditions

renal cell carcinoma (RCC)

Beyond the preview

Go deeper on jRCT1071250065.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1071250065.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call